| Name | KIRREL3 antisense RNA 2 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n KIRREL3‐AS2 is an antisense long non‐coding RNA whose functional role is beginning to emerge from studies across diverse biological contexts. On one hand, research into lncRNAs expressed in both gametogenic and cancer tissues has highlighted that many of these RNAs regulate key cellular processes such as telomere biology, chromatin dynamics, modulation of gene expression, and genome organization through pathways including Wnt/β‑catenin and PI3K/AKT/mTOR (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although KIRREL3‐AS2 is not directly discussed in this context, its classification among antisense lncRNAs suggests that it may similarly contribute to the fine‐tuning of gene expression programs shared by gametogenic and tumorigenic processes."}]}, {"type": "t", "text": "\n\n "}, {"type": "p", "children": [{"type": "t", "text": "\n On the other hand, transcriptome profiling in patients with drug‐refractory medial temporal lobe epilepsy (MTLE) has identified KIRREL3‐AS2 as one of a set of deregulated antisense RNAs. In this setting, its altered expression is part of a broader network involving genes central to synaptic transmission, neuronal network modulation, and neuroinflammatory pathways, providing new insights into the genomic underpinnings of epileptogenesis (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, while the precise mechanisms of KIRREL3‐AS2 remain to be fully elucidated, evidence from these studies implies that it may play a regulatory role—potentially impacting gene expression and cellular signaling—in both oncogenic/gametogenic processes and the pathophysiology of epilepsy.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ali Dianatpour, Soudeh Ghafouri-Fard "}, {"type": "b", "children": [{"type": "t", "text": "Long Non Coding RNA Expression Intersecting Cancer and Spermatogenesis: A Systematic Review"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian Pac J Cancer Prev (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.22034/APJCP.2017.18.10.2601"}], "href": "https://doi.org/10.22034/APJCP.2017.18.10.2601"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29072050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29072050"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Aparna Banerjee Dixit, Jyotirmoy Banerjee, Arpna Srivastava, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ygeno.2016.04.001"}], "href": "https://doi.org/10.1016/j.ygeno.2016.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27094248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27094248"}]}]}]}
|
| NCBI Gene ID | 100874251 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
KIRREL3-AS2 has 178 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 7 datasets.
Click the + buttons to view associations for KIRREL3-AS2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of KIRREL3-AS2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of KIRREL3-AS2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of KIRREL3-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of KIRREL3-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of KIRREL3-AS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of KIRREL3-AS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of KIRREL3-AS2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |